Task B31: Bulk Intermediate Scaleup for Antibiotic-Resistant Drug Design

$677.8K USD

Funder	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization	Eurofins Panlabs, Inc.
Country	United States
Start Date	Sep 13, 2024
End Date	Mar 12, 2025
Duration	180 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`11193623`

Grant Description

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins.

Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.